Cargando…
The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus
BACKGROUND: To evaluate the cost of diabetes related micro- and macrovascular complications in Iranian people with type 2 diabetes mellitus. METHODS: In routine clinical practice, people with type 2 diabetes mellitus were assessed for 10 years at a diabetes care center. The type of medications and c...
Autores principales: | Farshchi, Amir, Esteghamati, Alireza, Sari, Ali Akbari, Kebriaeezadeh, Abbas, Abdollahi, Mohammad, Dorkoosh, Farid Abedin, Khamseh, Mohamad Ebrahim, Aghili, Rokhsareh, Keshtkar, Abbas, Ebadi, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975900/ https://www.ncbi.nlm.nih.gov/pubmed/24593991 http://dx.doi.org/10.1186/2251-6581-13-42 |
Ejemplares similares
-
Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study
por: Farshchi, Amir, et al.
Publicado: (2016) -
Structured self monitoring of blood glucose in Iranian people with type 2 diabetes; A cost consequence analysis
por: Aghili, Rokhsareh, et al.
Publicado: (2012) -
“Annual Pharma Statistics” as a Health Information System Application in Iranian Pharmaceutical Sector
por: Farshchi, Amir, et al.
Publicado: (2015) -
An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012
por: Annabi, Majid, et al.
Publicado: (2017) -
Economic Burden of Hepatitis B Virus-Related Diseases: Evidence From Iran
por: Keshavarz, Khosro, et al.
Publicado: (2015)